Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > bought deal
View:
Post by woundedknee on Feb 04, 2021 9:42am

bought deal

last one was 30 cents ...multiply by 4 for this one.
Comment by woundedknee on Feb 04, 2021 9:50am
Just upsized to 20 million from 10 mil. Lots of cash now...
Comment by BioTeck on Feb 04, 2021 9:53am
Are we trying to raise enough money to buy ViaCyte? Lol
Comment by BioTeck on Feb 04, 2021 10:07am
A year ago the company was barely worth the amount of this PP. What could they possibly need 20 million for?
Comment by rixpix on Feb 04, 2021 10:12am
Good point, BioT. 20 Mill is substantial. Why raise so much now? Why not wait and raise more in 6 months when the SP might be higher?
Comment by smokeydabear on Feb 04, 2021 10:20am
Supply and demand?  Could be there was more institiutional money that wanted in on this so why not upsize it?
Comment by markeg on Feb 04, 2021 10:36am
Ya f&$kin dummy.  They needed more Michelobs. They want to cover 10 acres.
Comment by Bakunin6 on Feb 04, 2021 10:13am
The last clinical trial had 7 people in it...the next? Maybe hundreds. Going downtown to see my girl.
Comment by woundedknee on Feb 04, 2021 10:24am
Reverse split is next...nasdaq...jmo
Comment by Treesh on Feb 04, 2021 10:28am
agreed
Comment by BioTeck on Feb 04, 2021 12:35pm
I disagree. However, it could be something relating to potential partnership deal where company X will invest a certain amount into SVA for some kind of license rights. Most often large corporations will not invest a lot of money into companies that don't  have cash of their own on their books. It could also be a power move by Phil to show pharma we aren't desperate for their $. Or ...more  
Comment by woundedknee on Feb 04, 2021 1:11pm
As I said BioTeck...jmo. But they did say they were going for a NAZ listing. At this sp it's not possible.
Comment by JonEcash on Feb 04, 2021 1:16pm
I'm leaning towards what BioTeck is speculating. If it was just to be a reverse split everything would have been better planned. Why do the bought deal and then double it in less than 12 hours? This smells of things having to move very quickly for a specific, strategic purpose. I'm hearing it's not easy to get in on the bought deal either, which is a good sign. As others have said ...more  
Comment by woundedknee on Feb 04, 2021 1:28pm
When all the smoke clears it's a possibility that we are looking at close to 270mil shares and a 1/10 would make a naz listing a given. Again..jmo
Comment by BioTeck on Feb 04, 2021 1:29pm
I can confirm difficulty getting in on the placement. I have bought into SVA placements before and I am unable through my regular channels. I will try a few other contacts I have at Canaccord and Leede. I am told that demand for this is really high which is obvious by looking at the current share price trading 10 cents above PP price. 
Comment by Redbaron2211 on Feb 04, 2021 1:50pm
The fact that this placement happened at the same time as the Xetra exchange tells me Canaccord, Leede and whoever else are involved are giving some direction.  I'm sure it's obvious to them how undervalued this is compared to peers and will be able to give guidance.  They help with Xetra listing and hopefully push for a Nasdaq I don't see why they wouldn't and might have ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities